Global Insurtech Funding Rebounds in Q2 2024

Global insurtech funding rebounded in Q2 2024, driven by larger deal sizes despite a decline in overall deal count, according to Gallagher Re's quarterly analysis.
By: | August 5, 2024
Topics: Insurtech | News
insurtech funding

Global insurtech investment surged to $1.27 billion in the second quarter of 2024, marking the highest level since Q1 2023, according to Gallagher Re’s Q2 Global Insurtech Report.

The quarter witnessed a 39.7% increase in global insurtech funding, compared with the previous quarter. The main driver of the growth in insurtech funding was a near doubling of average deal sizes, which increased to $18.46 million in Q2 from $9.81 million in Q1, according to the report.

Leading this trend was health insurer Sidecar Health, which raised $165 million in a Series D round and was the sole mega-round deal of the year to date.

However, while total funding increased, the overall deal count saw a 23.4% decline to 82 deals in Q2 from 107 in Q1, the lowest quarterly count since Q2 2020. This drop was proportional across both the property & casualty (P&C) and life & health (L&H) insurance sectors, falling to 54 from 70 deals to 28 from 37 deals, respectively.

Early-Stage Insurtech Investment Trends

The second quarter of 2024 saw a significant shift in early-stage insurtech investments. Early-stage funding increased by 34.9% over Q1, reaching $377.6 million, which is the highest level since Q1 2023. This surge was primarily driven by a substantial increase in average early-stage deal sizes, which rose 77.8% to $8.58 million.

Early-stage deal count experienced a 21.9% decline, falling to just 50 deals. This pullback was attributed to a decrease in seed-stage deals, which dropped to 29 in Q2 from 45 in Q1.

The increase in funding coupled with a decrease in deal count suggests that investors are becoming more selective in their early-stage investments, focusing on larger deals with companies that demonstrate strong potential for growth and innovation in the insurtech space, according to Gallagher Re.

Insurtech Sector Focus

Insurtechs focused on artificial intelligence (AI) accounted for 32.9%, or 27 of the 82 deals in Q2, raising $445.8 million in funding. Of those 27 funding deals, 17 were for early-stage companies.

“These deals were smaller in size on average than companies not focused on AI,” Gallagher Re noted. “Interestingly, this is a reverse of what we observed in Q1 where AI insurtechs raised on average 20% more capital than their non-AI counterparts.”

Insurtechs focused on risk origination, or pricing/underwriting/portfolio optimization, accounted for 33, or 40.2% of the quarter’s deals. These companies raised $742.5 million in the quarter.

Among these risk-focused insurtechs, 18 were B2B companies, and the remainder were either digital insurers or risk-origination intermediaries, per the report.

Four of the top five funding deals in the quarter went to risk-focused insurtechs:

  • Sidecar Health, a health insurer raised $165 million in a Series D round.
  • ICEYE, a provider of data from satellites, raised $93 million in Series D.
  • Cover Genius, an embedded insurance provider, raised $80 million in Series E.
  • Honey Insurance, a homeowners’ insurance provider, raised $71 million in Series A.

View the full report on Gallagher Re’s website. &

The R&I Editorial Team can be reached at [email protected].

More from Risk & Insurance